Tag Archives | ADC antibody-drug conjugates

Biotechs Unhinged by Tough Pricing Talk

Biotechs Unhinged-Roiled by Commentary and Tweet storms Biotech stocks rallied briefly early in the week but sold off abruptly over the past two days with a quote from Trump in a Time Person of the Year article as saying, “I’m going to bring down drug prices”. This tough talk is reminiscent of comments by both […]

Continue Reading 0

Market Reversal in Biotech But Healthcare Stocks Are Still Muddled

Market Reversal in Biotech Offers Bullish Set-Up After one of the worst down days in months yesterday biotech stocks broadly reversed today giving a short term “nibble” signal. The macro environment got support from economic data as well with upward Q3 GDP revisions to 3.2% and higher consumer confidence data. The economy now has the […]

Continue Reading 0

Rayno Biobeat #4: Sector Shift Underway but what’s next for biotech?…Update-1

Update-1 November 28 Another nasty day for biotech A bit of a selloff in the market indices today with the NASDAQ down 0.58% and the S&P down 0.53%. The highly touted Russell 2000 (IWM) was down 1.3% after a 15 day rally. But the real wreck was in biotech with the XBI down 3.09% and […]

Continue Reading 0

Rayno Biobeat #3…Trump Biotech Rally Leads Market Up

Trump Election Win Drives Huge Biotech Rally NASDAQ up over 1% to 5248 The Trump biotech rally began at today’s opening up (IBB) 20 points to $280 then held to close  up 8.9% to $285. The XBI soared 10.4% to close at $63.8 near highs of day. The cloud of drug pricing concerns vanished because […]

Continue Reading 0

Rayno Biobeat #2…Good Value in Large Cap Biopharmaceuticals- Update-1

Which Large Cap Biopharma Stocks Have the Best Value? But revenue growth is slowing so M&A must pick up. Drug stocks have gone through a severe correction and healthcare is one of the worse sectors YTD. Although the key indicators are still sketchy, now is the time to look for value among several top large […]

Continue Reading 0

BIO Investor Forum October 18-19, 2016… Preview

BIO Investor Forum 2016 We will be attending the BIO Investor Forum beginning Tuesday October 18 for two days. Last year the meeting was excellent for coverage of small cap biotech companies and important issues and trends in the life science industry. Over 100 companies will present in 2016. Here are some links to selected […]

Continue Reading 0

Biotech Stocks Recovering from Last Week’s Free Fall: XBI…Update-2

Green Tape Today Shows Resilience– 10/10/16 ESMO Cancer Congress 4%+ Up movers: AGIO ARIA BLUE CLVS LGND PBYI TSRO etc. XBI up 2.39% More Bad Clinical News for Biotech:ALNY,CLVS The XBI lost 3.2% for the week to $64.15 taking a hit from Alnylam (ALNY) downdraft down 49% for the week. The IBB also took a […]

Continue Reading 0

Biotech Stocks Pause at Resistance: IBB…Update-2…Caution

Update-2… 9/29 Caution on Biotech-Major Sell-Off with IBB off 3.12% The market had a bad day today hit by Wells Fargo (WFC) Congressional hearings and paranoia about Deutsche Bank AG (DB). Unrelated to this news was a major sell-off in biotech stocks with pricing concerns back in the news. Voters in CA can vote on Proposition […]

Continue Reading 0

Biotech ETFs Lead Q3 Rally: XBI Breaks Out

Biotech ETFs Are Having A Strong Quarter and Offer Good Investment Options On July 20 we did a review of active funds vs biotech ETFs in the biotechnology/life science sector just after the BREXIT lows. At that time biotech ETFs and broadly diversified funds beat the “pure play” biotechnology funds such as Fidelity Select Biotechnology Portfolio […]

Continue Reading 0

Stealth Biotech Rally With Momentum Rising…Update-1

Update-1…FED Goes on Hold with Rate Increase Likely by Year End Three on FOMC dissented wanting a rate hike this round. Market immediately rallied with NASDAQ up 1.03% at close; S&P and Dow also rally. Biotechs like low i rates:IBB up 0.62% to $297, XBI up 1.14% to $68.28 highest level since January but still […]

Continue Reading 0